Investigation of the Efficacy of a VR Exposure-based Eye Contact Training to Reduce Fear of Publ… (NCT03970187) | Clinical Trial Compass
CompletedNot Applicable
Investigation of the Efficacy of a VR Exposure-based Eye Contact Training to Reduce Fear of Public Speaking
Switzerland96 participantsStarted 2019-06-01
Plain-language summary
Investigation of the efficacy of an eye contact training App in virtual reality, based on principles of exposure therapy for the treatment for subjects with fear of public speaking.
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Fear of public speaking, assessed by two separate aspects:
* High fear in social situations including the potential of being evaluated by others
* Social situations can only be withstood under high fear or are avoided
* Aged between 18-40
* Fluent in German
Exclusion Criteria:
* BDI-II sumscore \>= 20
* Suicidal ideation (BDI-II item 9 \> 0)
* Serious medical or psychological condition, other than social anxiety (including Depression, Epilepsy and Migraine)
* Concurrent psychotherapy
* Previous exposure-based therapy for social anxiety (including public speaking anxiety) or other anxiety disorders
* Parallel participation in another psychological or medical study
* Chronic medication intake (except oral contraceptives)
* Chronic drug intake (i.e. LSD, mushrooms, Ecstasy, MDMA, amphetamines etc.)
* Medication intake before visits (less than 24 h)
* Alcohol intake before visits (less than 12 h)
* Cannabis or other psychoactive substances (including benzodiazepines) intake before visits (less than 5 days)
* Restricted 3D sight
* For women: Current pregnancy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Subjective Units of Distress Scale (SUDS, fear)
Timeframe: Assessing change between baseline and predefined follow-up time points during 11 weeks